Monash’s research infrastructure unites world-class facilities, technologies, and expertise across four key capability areas: drug discovery and development, biomedical and life sciences, advanced ...

Pioneering sustainable solutions with world-class fabrication, characterisation, and industry-ready innovation.

Pioneering new treatments through cutting-edge research and translational drug development.

Provides expertise in advanced electron microscopy for biomedical discoveries at molecular and cellular level. Provides a comprehensive service in animal and cell genome modification as well as DNA ...

Monash University spinout RAGE Biotech has raised $29 million in Series A funding, marking a major step toward translating ...

Adherence to cholesterol-lowering treatments remains one of the biggest challenges in preventing heart disease. The one-time ...

The study also revealed that harassment experienced during adolescence continues to affect women’s perceptions of safety well ...

The AI for Law Enforcement and Community Safety (AiLECS) Lab, a collaboration between the AFP and Monash University, is developing a new disruption tool which, among its broad applications, can slow ...

Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with autism or ADHD in children, finds an in-depth evidence review published by The BMJ, in direct response to ...

“Highly Cited researchers are synonymous with excellence. This year’s result, with 27 Monash researchers identified on the Clarivate list, continues a trend of growing our HiCi cohort, increasing from ...

Seven researchers from across Monash have been newly appointed to the Australian Research Council College of Experts for 2026 - a recognition of their outstanding research excellence, leadership and ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to heart pump treatments and are left with only medication or palliative care.